A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
Clinical trial NCT04567615 · COMPLETED
Trial details
- NCT number
- NCT04567615
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2023-08-31
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.